Macquarie Group LTD Abb Vie Inc. Transaction History

Macquarie Group LTD

  • $83.5 Billion
  • Q3 2025

A detailed history of Macquarie Group LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 934,485 shares of ABBV stock, worth $219 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
934,485
Previous 596,574 56.64%
Holding current value
$219 Million
Previous $111 Million 95.39%
% of portfolio
0.26%
Previous 0.14%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
BUY
$184.85 - $231.54 $62.5 Million - $78.2 Million
337,911 Added 56.64%
934,485 $216 Million
Q2 2025

Aug 14, 2025
SELL
$170.16 - $206.27 $35.8 Million - $43.4 Million
-210,412 Reduced 26.07%
596,574 $111 Million
Q1 2025

May 15, 2025
BUY
$169.2 - $216.66 $14.3 Million - $18.3 Million
84,265 Added 11.66%
806,986 $169 Million
Q4 2024

Feb 14, 2025
BUY
$164.99 - $203.87 $32.5 Million - $40.1 Million
196,709 Added 37.4%
722,721 $128 Million
Q3 2024

Nov 14, 2024
BUY
$163.84 - $199.33 $4.24 Million - $5.15 Million
25,858 Added 5.17%
526,012 $104 Million
Q2 2024

Aug 09, 2024
BUY
$154.79 - $180.76 $8.7 Million - $10.2 Million
56,229 Added 12.67%
500,154 $85.8 Million
Q1 2024

May 14, 2024
SELL
$159.82 - $182.1 $11.5 Million - $13.1 Million
-71,668 Reduced 13.9%
443,925 $80.8 Million
Q4 2023

Feb 14, 2024
SELL
$137.6 - $154.97 $34.2 Million - $38.5 Million
-248,602 Reduced 32.53%
515,593 $79.9 Million
Q3 2023

Nov 14, 2023
BUY
$133.59 - $154.65 $43.2 Million - $50 Million
323,367 Added 73.35%
764,195 $114 Million
Q2 2023

Aug 14, 2023
SELL
$132.51 - $164.9 $8.99 Million - $11.2 Million
-67,809 Reduced 13.33%
440,828 $59.4 Million
Q1 2023

May 15, 2023
BUY
$144.61 - $166.54 $7.53 Million - $8.67 Million
52,064 Added 11.4%
508,637 $81.1 Million
Q4 2022

Feb 21, 2023
BUY
$138.31 - $165.87 $2.61 Million - $3.13 Million
18,881 Added 4.31%
456,573 $73.8 Million
Q3 2022

Nov 14, 2022
SELL
$134.21 - $153.93 $4.17 Million - $4.78 Million
-31,065 Reduced 6.63%
437,692 $58.7 Million
Q2 2022

Aug 15, 2022
SELL
$137.62 - $174.96 $14.4 Million - $18.4 Million
-104,976 Reduced 18.3%
468,757 $71.8 Million
Q1 2022

May 16, 2022
SELL
$131.98 - $163.75 $21.4 Million - $26.5 Million
-161,885 Reduced 22.01%
573,733 $93 Million
Q4 2021

Feb 11, 2022
SELL
$107.43 - $135.93 $2.5 Million - $3.17 Million
-23,294 Reduced 3.07%
735,618 $99.6 Million
Q3 2021

Nov 12, 2021
SELL
$106.4 - $120.78 $14.5 Million - $16.4 Million
-135,931 Reduced 15.19%
758,912 $81.9 Million
Q2 2021

Aug 13, 2021
SELL
$105.21 - $117.21 $7.87 Million - $8.77 Million
-74,827 Reduced 7.72%
894,843 $101 Million
Q1 2021

May 14, 2021
BUY
$102.3 - $112.62 $30.4 Million - $33.5 Million
297,561 Added 44.27%
969,670 $105 Million
Q4 2020

Feb 16, 2021
BUY
$80.49 - $108.67 $10 Million - $13.6 Million
124,760 Added 22.79%
672,109 $72 Million
Q3 2020

Nov 13, 2020
BUY
$85.91 - $100.83 $9.65 Million - $11.3 Million
112,365 Added 25.83%
547,349 $47.9 Million
Q2 2020

Aug 11, 2020
BUY
$73.37 - $98.18 $10.3 Million - $13.8 Million
140,866 Added 47.89%
434,984 $42.7 Million
Q1 2020

May 15, 2020
BUY
$64.5 - $97.79 $8.19 Million - $12.4 Million
126,981 Added 75.97%
294,118 $22.4 Million
Q4 2019

Feb 14, 2020
SELL
$72.13 - $90.25 $201,819 - $252,519
-2,798 Reduced 1.65%
167,137 $14.8 Million
Q3 2019

Nov 14, 2019
SELL
$62.98 - $75.72 $4.62 Million - $5.55 Million
-73,287 Reduced 30.13%
169,935 $12.9 Million
Q2 2019

Aug 14, 2019
SELL
$65.7 - $83.98 $767,376 - $980,886
-11,680 Reduced 4.58%
243,222 $17.7 Million
Q1 2019

May 15, 2019
SELL
$77.14 - $90.79 $291,589 - $343,186
-3,780 Reduced 1.46%
254,902 $20.5 Million
Q4 2018

Feb 15, 2019
SELL
$77.85 - $96.01 $12.1 Million - $14.9 Million
-154,986 Reduced 37.47%
258,682 $23.8 Million
Q3 2018

Nov 15, 2018
SELL
$88.91 - $98.84 $2.54 Million - $2.83 Million
-28,620 Reduced 6.47%
413,668 $39.1 Million
Q2 2018

Aug 14, 2018
BUY
$89.78 - $106.23 $1.16 Million - $1.37 Million
12,938 Added 3.01%
442,288 $41 Million
Q1 2018

May 11, 2018
SELL
$92.01 - $123.21 $4.72 Million - $6.32 Million
-51,316 Reduced 10.68%
429,350 $40.6 Million
Q4 2017

Feb 15, 2018
BUY
$89.56 - $98.21 $12.9 Million - $14.1 Million
143,538 Added 42.58%
480,666 $46.6 Million
Q3 2017

Nov 08, 2017
BUY
$69.85 - $89.22 $23.5 Million - $30.1 Million
337,128
337,128 $30 Million

Others Institutions Holding ABBV

# of Institutions
4,489
Shares Held
1.28B
Call Options Held
16.9M
Put Options Held
15.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email